Last reviewed · How we verify
NCT06270849
Validity and Reliability of ICIQ-FLUTS LF in Thai Version and Correlation With IPSS
trial testing Questionnaire in Validity of Thai Version of the ICIQ-FLUTS LF Questionnaire in 130 participants. Completed in 20 January 2024.
31 December 2023
Quick facts
| Lead sponsor | Thammasat University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 24 February 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 20 January 2024 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Questionnaire
Conditions studied
- Validity of Thai Version of the ICIQ-FLUTS LF Questionnaire — all drugs for Validity of Thai Version of the ICIQ-FLUTS LF Questionnaire →
- Reliability of Thai Version of the ICIQ-FLUTS LF — all drugs for Reliability of Thai Version of the ICIQ-FLUTS LF →
Sponsor
Thammasat University Hospital
Who can join
Adults 18 to 60, female only, with Validity of Thai Version of the ICIQ-FLUTS LF Questionnaire or Reliability of Thai Version of the ICIQ-FLUTS LF. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators recruited participants, who were female with LUTS 50 participants for known group validity and 80 normal control females to evaluate for construct validity and test for reliability by statistical analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06270849
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire
Trials testing the same drug.
- NCT04466371 — Perceptions of Undergraduate Students and Teaching Staff on Online Teaching · suspended
- NCT07089953 — Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomiz · NA · not yet recruiting
- NCT07418775 — Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma · not yet recruiting
- NCT07226804 — Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules · not yet recruiting
- NCT07532954 — The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support · recruiting
Other Thammasat University Hospital trials
Trials by the same sponsor.
- NCT06910930 — Impact of Muscle Training Device on Non-Severe OSA · NA · recruiting
- NCT06943053 — Evaluation of Ioband Coverage Waterproof Dressing Versus Isolated Waterproof Dressing After Primary Total Knee Arthropla · NA · recruiting
- NCT06800846 — Comparative Analgesic Effect After Total Knee Arthroplasty Between Intraosseous and Peri-articular Injection · Phase 4 · enrolling by invitation
- NCT06328062 — Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA · NA · recruiting
- NCT06323577 — Comparing Efficacy Between Restricted Kinematic Alignment vs Mechanical Alignment in Bilateral TKA · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06270849 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thammasat University Hospital
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06270849.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing